• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Harvard Bioscience (NQ: HBIO )

    2.370 -0.030 (-1.25%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Harvard Bioscience

    < Previous 1 2 Next >
    Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024
    New products complement an already extensive range of products enabling fundamental advancements in neuroscience research 
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting
    Solutions for CROs, pharma and biotechs streamline testing and enable fundamental advancements in preclinical and organoid focused therapy development 
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Announces Second Quarter 2024 Financial Results
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Announces First Quarter 2024 Financial Results
    Strong gross margin performance and focus on efficiency to support ongoing investments in growth 
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
    Solutions for CROs, pharma and biotechs improve throughput and efficiency and enable future advancements in data analytics 
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Announces Third Quarter 2023 Financial Results
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023
    Innovative solutions for academic, CRO, pharma and biotech customers 
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research
    From Harvard Bioscience, Inc.; Etisense
    Via GlobeNewswire
    Harvard Bioscience Announces Second Quarter 2023 Financial Results
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Schedules Second Quarter 2023 Earnings Conference Call for August 8, 2023 at 8:00 AM ET
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Set to Join Russell 2000® and 3000® Indexes
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
    Has served in interim role since January 2023 
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience to Present at Sidoti Micro Cap Virtual Conference May 10th, 2023
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Announces First Quarter 2023 Financial Results
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Announces Initial Order for Integrated Animal Behavior Monitoring System
    Designed to meet the pre-clinical testing needs of CROs, pharma and research laboratories 
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Schedules First Quarter 2023 Earnings Conference Call for April 25, 2023 at 9:00 AM ET
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.